200 related articles for article (PubMed ID: 37235687)
1. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
Manevski N; Umehara K; Parrott N
Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687
[TBL] [Abstract][Full Text] [Related]
2. A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.
Andrews-Morger A; Reutlinger M; Parrott N; Olivares-Morales A
Mol Pharm; 2023 Oct; 20(10):5052-5065. PubMed ID: 37713584
[TBL] [Abstract][Full Text] [Related]
3. In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.
Tess D; Chang GC; Keefer C; Carlo A; Jones R; Di L
AAPS J; 2023 Apr; 25(3):40. PubMed ID: 37052732
[TBL] [Abstract][Full Text] [Related]
4. Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules.
Trunzer M; Teigão J; Huth F; Poller B; Desrayaud S; Rodríguez-Pérez R; Faller B
Drug Metab Dispos; 2024 Apr; 52(5):345-354. PubMed ID: 38360916
[TBL] [Abstract][Full Text] [Related]
5. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
Kosugi Y; Hosea N
Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
[TBL] [Abstract][Full Text] [Related]
6. The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance.
Keefer CE; Chang G; Di L; Woody NA; Tess DA; Osgood SM; Kapinos B; Racich J; Carlo AA; Balesano A; Ferguson N; Orozco C; Zueva L; Luo L
Mol Pharm; 2023 Nov; 20(11):5616-5630. PubMed ID: 37812508
[TBL] [Abstract][Full Text] [Related]
7. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species.
Tess DA; Ryu S; Di L
Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289
[TBL] [Abstract][Full Text] [Related]
8. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
Francis LJ; Houston JB; Hallifax D
Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
[TBL] [Abstract][Full Text] [Related]
9. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
Poulin P
J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
[TBL] [Abstract][Full Text] [Related]
10. Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologically Based Models? A Feasibility Study Based on 12 Development Compounds.
Parrott N; Manevski N; Olivares-Morales A
Mol Pharm; 2022 Nov; 19(11):3858-3868. PubMed ID: 36150125
[TBL] [Abstract][Full Text] [Related]
11. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
Poulin P; Haddad S
J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
[TBL] [Abstract][Full Text] [Related]
13. Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction.
Umehara K; Cantrill C; Wittwer MB; Di Lenarda E; Klammers F; Ekiciler A; Parrott N; Fowler S; Ullah M
Drug Metab Dispos; 2020 Oct; 48(10):849-860. PubMed ID: 32739889
[TBL] [Abstract][Full Text] [Related]
14. Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.
Bowman CM; Benet LZ
Pharm Res; 2019 May; 36(8):113. PubMed ID: 31152241
[TBL] [Abstract][Full Text] [Related]
15. Application of empirical scalars to enable early prediction of human hepatic clearance using IVIVE in drug discovery: an evaluation of 173 drugs.
Jones RS; Leung C; Chang JH; Brown S; Liu N; Yan Z; Kenny JR; Broccatelli F
Drug Metab Dispos; 2022 May; ():. PubMed ID: 35636770
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance.
Williamson B; Harlfinger S; McGinnity DF
Drug Metab Dispos; 2020 Nov; 48(11):1137-1146. PubMed ID: 32847864
[TBL] [Abstract][Full Text] [Related]
17. Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways.
Benet LZ; Sodhi JK
AAPS J; 2020 Sep; 22(5):120. PubMed ID: 32914238
[TBL] [Abstract][Full Text] [Related]
18. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
[TBL] [Abstract][Full Text] [Related]
19. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
Kosugi Y; Hosea N
Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
